Open AccessP025: RADAR: An international phase III, PET response‐adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited‐stage classical Hodgkin lymphoma
Author(s) -
Radford John,
Adedayo Toyin,
Ardavan Arzhang,
Barrington Sally F.,
Berkahn Leanne,
Chauvie Stephane,
CliftonHadley Laura,
Collins Graham P.,
Crump Michael,
Cutter David,
Edwards Darren,
Hutchings Martin,
Illidge Tim,
Kirkwood Amy A.,
Linton Kim,
Moskowitz Craig H.,
Patrick Pip,
Phillips Beth,
Shepherd Lois,
Tonino Sanne,
Trotman Judith,
Williams Joanna,
Doo Nicole Wong
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000890668.27643.97
Subject(s) - brentuximab vedotin , abvd , medicine , dacarbazine , oncology , vinblastine , clinical trial , chemotherapy regimen , surgery , chemotherapy , lymphoma , cd30 , vincristine , cyclophosphamide